MRD monitoring in acute lymphoblastic leukemia treatment

被引：0
|
作者：
Sanada, Masashi [1 ]
机构：
[1] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.430
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY6-3
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [1] Role of MRD monitoring in acute lymphoblastic leukemia after allogeneic transplantation
    Bonanomi, BS
    Dassi, DM
    Manenti, MM
    Riva, RMR
    Songia, SS
    Perseghin, PP
    Mascaretti, ML
    Uderzo, UC
    Biondi, BA
    Balduzzi, BA
    BONE MARROW TRANSPLANTATION, 2005, 35 : S95 - S95
  • [2] Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia
    Sawada, Akihisa
    Sakata, Naoki
    Kishimoto, Tomoko
    Higuchi, Banryoku
    Koyama, Maho
    Kondo, Osamu
    Sato, Emiko
    Okamura, Takayuki
    Yasui, Masahiro
    Inoue, Masami
    Yoshioka, Akira
    Kawa, Keisei
    LEUKEMIA RESEARCH, 2009, 33 (12) : 1710 - 1713
  • [3] Role of MRD monitoring in childhood acute lymphoblastic leukemia after allogeneic transplantation.
    Balduzzi, A
    Bonanomi, S
    Manenti, M
    Dassi, M
    Cazzaniga, G
    Riva, MR
    Songia, S
    Perseghin, P
    Mascaretti, L
    Uderzo, C
    Biondi, A
    BLOOD, 2004, 104 (11) : 281A - 281A
  • [4] IMMUNOPHENOTYPIC MODULATION IN ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSTIVE MRD AFTER INDUCTION TREATMENT
    Barba, P.
    Aventin, A.
    Ubeda, J.
    Carricondo, M.
    Martino, R.
    Badell, I.
    Parente, A.
    Bussaglia, E.
    Estivill, C.
    Sierra, J.
    Nomdedeu, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 252 - 252
  • [5] The significance of MRD quantity monitoring in acute leukemia
    Tong, C.
    Cai, P.
    Lin, Y.
    Liu, H.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 118 - 118
  • [6] Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
    Litzow, M. R.
    Sun, Z.
    Mattison, R. J.
    Paietta, E. M.
    Roberts, K. G.
    Zhang, Y.
    Racevskis, J.
    Lazarus, H. M.
    Rowe, J. M.
    Arber, D. A.
    Wieduwilt, M. J.
    Liedtke, M.
    Bergeron, J.
    Wood, B. L.
    Zhao, Y.
    Wu, G.
    Chang, T-C
    Zhang, W.
    Pratz, K. W.
    Dinner, S. N.
    Frey, N.
    Gore, S. D.
    Bhatnagar, B.
    Atallah, E. L.
    Uy, G. L.
    Jeyakumar, D.
    Lin, T. L.
    Willman, C. L.
    DeAngelo, D. J.
    Patel, S. B.
    Elliott, M. A.
    Advani, A. S.
    Tzachanis, D.
    Vachhani, P.
    Bhave, R. R.
    Sharon, E.
    Little, R. F.
    Erba, H. P.
    Stone, R. M.
    Luger, S. M.
    Mullighan, C. G.
    Tallman, M. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 320 - 333
  • [7] INVESTIGATIONAL MARKERS FOR MRD IN B LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA
    Misra, Aroonima
    Chopra, Anita
    Soni, Shushant
    Bakhshi, Sameer
    Seth, Rachna
    Kumar, Rajive
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 71 - 72
  • [8] Clinical Significance and Management of MRD in Adults With Acute Lymphoblastic Leukemia
    Akabane, Hugo
    Logan, Aaron C.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (07) : 413 - 422
  • [9] Monitoring MRD Guided Treatment Outcome of Adult Patients with Acute Lymphoblastic Leukemia Using ALL-BFM95 Based Protocol
    Liang, Stephen Yang
    BLOOD, 2017, 130
  • [10] Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia
    Zhang, R.
    Yang, J. Y.
    Sun, H. Q.
    Jia, H.
    Liao, J.
    Shi, Y. J.
    Li, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (14) : 2679 - 2688
12345